This led to the current view that bHLH oncogenic transcription factors that include SCL (or TAL1), TAL2 and LYL1 form inactive transcriptional complexes that induce T-ALL via inhibition of E proteins (reviewed in [49], [56]). The gene discussed is LYL1; the disease is acute lymphoblastic leukemia.